T49.4X2
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T49.4X2 refers to cases where individuals intentionally ingest or misuse keratolytics, keratoplastics, or other hair treatment drugs, leading to poisoning. This condition is associated with self-harm behaviors, often as part of an effort to harm oneself physically. Such incidents require medical attention to manage symptoms and address underlying mental health issues. Recognizing the causes, symptoms, and treatment options is essential for healthcare providers, though this information is intended for informational purposes only.
Causes & Symptoms
Clinical Causes: Intentional self-harm or suicide attempts involving ingestion of hair treatment drugs Misuse of hair care products due to lack of understanding of their toxicity Mental health conditions such as depression or suicidal ideation leading to deliberate poisoning Accidental ingestion in individuals with cognitive impairments or young children
Key Symptoms: Gastrointestinal symptoms including nausea, vomiting, and abdominal pain Skin reactions such as redness, itching, or rashes if topical application occurs Signs of toxicity depending on the specific compounds involved Dizziness, weakness, or fatigue In severe cases, neurological symptoms like confusion, seizures, or loss of consciousness
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive medical evaluation including a review of the patient’s history and recent exposures. Blood tests may be performed to detect levels of specific chemicals or toxins. Additional assessments might include imaging or other diagnostic tools to rule out complications from poisoning. Mental health evaluations are also crucial to assess intent and underlying psychological factors.
Treatment Protocols: Treatment strategies focus on stabilizing the patient, preventing further absorption of toxins, and managing symptoms. Common interventions include: - Immediate decontamination methods such as activated charcoal or gastric lavage - Supportive care with intravenous fluids and medications to manage symptoms - Use of specific antidotes if applicable to the particular chemical involved - Monitoring for and treating complications like respiratory distress or neurological impairment - Psychological support to address underlying mental health issues and prevent recurrence of self-harm behaviors Follow-up care often involves coordination with mental health professionals to provide counseling, therapy, or psychiatric treatment tailored to the patient’s needs.
Clinical Advice & FAQs
Billing Guidance
Is T49.4X2 a billable ICD-10 code?
Yes, T49.4X2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T49.4X2?
Clinical documentation must specify the nature of Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
